Heart Valve Deaths Rise After Decades of Decline

After nearly two decades of declining mortality, heart valve disease deaths among U.S. adults aged 65 and older have begun to rise. Preliminary research indicates this reversal started in 2018 and is projected to persist through 2040, contrary to earlier expectations of continued decrease. This trend is attributed to the increasing complexity of patient health profiles, with longer lifespans often accompanied by multiple chronic conditions.

The study, analyzing data from 1999 to 2023, found the death rate per 100,000 people climbed from its pre-pandemic low to 109.2 in 2023. Men, non-Hispanic white adults, and those in non-metropolitan areas experienced higher death rates. Experts highlight that cumulative impacts of conditions like heart failure, frailty, and kidney disease, rather than valve disease alone, often contribute to mortality.

Concerns also surround access to specialist care, particularly for those in rural areas who may face significant travel distances. Efforts like the American Heart Association's Target: Aortic Stenosis initiative aim to improve early diagnosis and timely treatment. Researchers caution that data limitations, including potential coding inaccuracies and the influence of the COVID-19 pandemic, should be considered when interpreting these findings.